T2 Biosystems Inc (TTOO):企業の製品パイプライン分析2018

【英語タイトル】T2 Biosystems Inc (TTOO) - Product Pipeline Analysis, 2018 Update

GlobalDataが出版した調査資料(DATA904C2868)・商品コード:DATA904C2868
・発行会社(調査会社):GlobalData
・発行日:2018年8月
・ページ数:40
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Summary
T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. T2 Biosystems also offers pipeline products for sepsis management, including bacterial resistance panels, and testing for the superbug Candida auris and a Lyme disease panel. The company’s products provide species-specific identification directly from whole blood. It offers hemostasis measurements from unpurified clinical samples in hospitals, labs and physicians’ offices. T2 Biosystems is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company T2 Biosystems Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
T2 Biosystems Inc Company Overview 5
T2 Biosystems Inc Company Snapshot 5
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview 5
T2 Biosystems Inc – Pipeline Analysis Overview 8
T2 Biosystems Inc – Key Facts 8
T2 Biosystems Inc – Major Products and Services 9
T2 Biosystems Inc Pipeline Products by Development Stage 10
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 12
T2 Biosystems Inc Pipeline Products Overview 14
Gram-Negative Resistance Panel 14
Gram-Negative Resistance Panel Product Overview 14
T2Dx – Antimicrobial Resistance 15
T2Dx – Antimicrobial Resistance Product Overview 15
T2Dx – Cancer 16
T2Dx – Cancer Product Overview 16
T2Dx – Cardiac 17
T2Dx – Cardiac Product Overview 17
T2Endotoxin 18
T2Endotoxin Product Overview 18
T2HemoStat 19
T2HemoStat Product Overview 19
T2Lyme Panel 20
T2Lyme Panel Product Overview 20
T2Lyme Panel Clinical Trial 21
T2MR Assay – Platelet Function Testing 22
T2MR Assay – Platelet Function Testing Product Overview 22
T2Plex 23
T2Plex Product Overview 23
T2 Biosystems Inc – Key Competitors 24
T2 Biosystems Inc – Key Employees 25
T2 Biosystems Inc – Key Employee Biographies 26
T2 Biosystems Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
T2 Biosystems Inc, Recent Developments 28
Jun 13, 2018: Late-Breaking Data and Clinician Reviews on Now FDA-cleared T2Bacteria Panel Underscore Sepsis Prevention Opportunities at ASM Microbe 2018 28
May 29, 2018: T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens 29
May 08, 2018: T2 Biosystems Announces First Quarter 2018 Financial Results 29
Mar 28, 2018: Multiple New Studies Demonstrate T2 Biosystems’ Diagnostics Improve Detection of Sepsis Causing Pathogens Over Blood Culture-based Diagnostics 30
Mar 06, 2018: T2 Biosystems Reports Fourth Quarter and Full-Year 2017 Financial Results and Business Update 31
Feb 09, 2018: Two New Studies Demonstrate T2Candida’s Advantages over Current Diagnostic Testing 32
Feb 05, 2018: T2 Biosystems Names John Sprague As CFO 33
Jan 04, 2018: T2 Biosystems Announces Preliminary Fourth Quarter 2017 Financial Results and Provides Update on T2Bacteria Panel 34
Nov 20, 2017: T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017 34
Nov 09, 2017: T2 Biosystems Announces Presentation on T2Sepsis Solution at AMP 2017 35
Appendix 37
Methodology 37
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
T2 Biosystems Inc Pipeline Products and Ongoing Clinical Trials Overview 5
T2 Biosystems Inc Pipeline Products by Equipment Type 6
T2 Biosystems Inc Pipeline Products by Indication 7
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 7
T2 Biosystems Inc, Key Facts 8
T2 Biosystems Inc, Major Products and Services 9
T2 Biosystems Inc Number of Pipeline Products by Development Stage 10
T2 Biosystems Inc Pipeline Products Summary by Development Stage 11
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 12
T2 Biosystems Inc Ongoing Clinical Trials Summary 13
Gram-Negative Resistance Panel - Product Status 14
Gram-Negative Resistance Panel - Product Description 14
T2Dx - Antimicrobial Resistance - Product Status 15
T2Dx - Antimicrobial Resistance - Product Description 15
T2Dx - Cancer - Product Status 16
T2Dx - Cancer - Product Description 16
T2Dx - Cardiac - Product Status 17
T2Dx - Cardiac - Product Description 17
T2Endotoxin - Product Status 18
T2Endotoxin - Product Description 18
T2HemoStat - Product Status 19
T2HemoStat - Product Description 19
T2Lyme Panel - Product Status 20
T2Lyme Panel - Product Description 20
T2Lyme Panel - Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel 21
T2MR Assay - Platelet Function Testing - Product Status 22
T2MR Assay - Platelet Function Testing - Product Description 22
T2Plex - Product Status 23
T2Plex - Product Description 23
T2 Biosystems Inc, Key Employees 25
T2 Biosystems Inc, Key Employee Biographies 26
T2 Biosystems Inc, Other Locations 27
Glossary 39

List of Figures
T2 Biosystems Inc Pipeline Products by Equipment Type 6
T2 Biosystems Inc Pipeline Products by Development Stage 10
T2 Biosystems Inc Ongoing Clinical Trials by Trial Status 12

★調査レポート[T2 Biosystems Inc (TTOO):企業の製品パイプライン分析2018] (コード:DATA904C2868)販売に関する免責事項を必ずご確認ください。
★調査レポート[T2 Biosystems Inc (TTOO):企業の製品パイプライン分析2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆